Grants and Contracts Details
Description
The capacity to distinguish among subclasses of pathology affects how aggressively patients
are treated, which medications are appropriate, and what levels of risk are justified. Current
therapies and treatment regimens are often based upon classification strategies which are
limited in terms of their capacity to discriminate among specific tumor groups. Recent
technological advances make it possible to analyze tumors at the genomic, RNA, and protein
expression level. Tissue microarrays (TMA) enable investigators to confirm clinico-pathologic
correlations which have been identified in whole histology slide tissue sections. Unfortunately,
one of the primary contributing factors leading to inconsistencies during the evaluation process
arises from the inherent, subjective impressions of the individuals performing the assessment.
The literature, including several systematic studies conducted by our team, shows that when
characterizations are based upon computer-aided analysis, objectivity, reproducibility and
sensitivity improve considerably. Advanced imaging and computational tools could potentially
enable investigators to detect and track subtle changes in measurable parameters leading to
the discovery of novel diagnostic and prognostic clues which are not apparent by human visual
inspection alone.
Status | Finished |
---|---|
Effective start/end date | 9/1/13 → 8/31/14 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.